Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?

@article{Kenkre2015ReassessmentOF,
  title={Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?},
  author={Julia S Kenkre},
  journal={Annals of clinical biochemistry},
  year={2015},
  volume={52 1},
  pages={183}
}

Similar Papers

Loading similar papers…